Michael is an operational and commercialization consultant and executive specializing in creating and scaling science-driven organizations emerging from academic, clinical, and government research environments. At ScienceDocs, he partners with founders, principal investigators, and early-stage companies to translate complex technologies into structured, fundable, and commercially viable businesses. With deep experience in regulated service environments, company formation, licensing, and capital strategy, Michael helps leadership teams design the operating systems, financial models, and commercialization roadmaps required to move from innovation to sustainable growth.

Services:

· Commercialization Strategy Development (Diagnostics, Medical Devices, Therapeutics)

· SBIR/STTR Commercialization Plans (Phase I & Phase II)

· Company Formation & Corporate Structure

· Technology Licensing & Negotiation (Universities, Hospitals, Government Labs)

· Capital Strategy & Investor Readiness (Friends & Family, Angels, VC, Family Offices)

· Multi-Scenario Pro Forma Development

· Cap Tables

· Operational Infrastructure Design & KPI Dashboard Implementation

· Investor Slide Deck Preparation & Pitch Optimization

· Board Governance, Data Room Preparation & Due Diligence Support

· Term Sheets

Experience:

In addition to his consulting work with ScienceDocs as a Senior Commercialization Consultant, Michael has founded or supported the launch of more than 20 companies across, biotechnology, diagnostics, medical devices, healthcare services and other industries. He has negotiated numerous technology licenses, structured spinout entities from academic institutions, and helped raise more than $25 million in dilutive and non-dilutive funding. He has led organizations through stabilization, operational restructuring, and scalable growth—driving 500% revenue expansion while reducing cost structures by 30% through disciplined forecasting and execution. His leadership experience includes serving as President and CFO of life sciences ventures, Managing Director of a biotech commercialization firm, and senior roles in global structured finance. He is recognized for bringing structure, clarity, and execution discipline to complex, regulated environments where accuracy, compliance, and client trust are paramount.

Education:

Michael holds an MBA from the Thunderbird School of Global Management and a Bachelor of Science in Finance from the University of Arizona. His background integrates financial discipline, operational leadership, and entrepreneurial execution across both domestic and international markets.

To work with Commercialization and Operations Consultant Mr. Michael, please visit our quote page and request him in the description area.